Van Leeuwen & Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
El Paso Energy Capital Trust I
EP.PRC
|
+$3.88M |
| 2 |
Estee Lauder
EL
|
+$2M |
| 3 |
Blackstone
BX
|
+$1.88M |
| 4 |
Comcast
CMCSA
|
+$1.53M |
| 5 |
Vail Resorts
MTN
|
+$920K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.88M |
| 2 |
Cisco
CSCO
|
+$1.74M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.57M |
| 4 |
Darden Restaurants
DRI
|
+$1.57M |
| 5 |
Ross Stores
ROST
|
+$1.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.13% |
| 2 | Technology | 13.29% |
| 3 | Financials | 12.94% |
| 4 | Healthcare | 9.51% |
| 5 | Communication Services | 8.93% |
Similar funds
Van Leeuwen & Company's Q3 2019 Portfolio in Review
As of Q3 2019, Van Leeuwen & Company held 83 positions worth $106M, down 4.9% from $111M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Van Leeuwen & Company withdrew a net $5.53M in Q3 2019, closing 11 positions and reducing 38 holdings. Its most notable exit was Pfizer, an estimated $1.88M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
Against the trend, Van Leeuwen & Company opened a new position in El Paso Energy Capital Trust I worth $1.54M.
- Van Leeuwen & Company's largest Q3 2019 buy was El Paso Energy Capital Trust I: 74,738 shares worth $1.54M.
- Van Leeuwen & Company added most to Comcast in Q3 2019, an estimated $1.53M increase.
- Van Leeuwen & Company's biggest Q3 2019 reduction was Bristol-Myers Squibb, cutting an estimated $1.57M.
- Van Leeuwen & Company fully exited Pfizer in Q3 2019, selling an estimated $1.88M.
- Van Leeuwen & Company's ten largest holdings make up 35% of its $106M portfolio in Q3 2019.
- Van Leeuwen & Company opened 8 new positions and closed 11 in Q3 2019.
- Van Leeuwen & Company's portfolio value fell 4.9% quarter-over-quarter to $106M.
Based on Van Leeuwen & Company's 13F filing for Q3 2019, filed 12 Nov 2019.